iRhythm Technologies Inc

Stock Chart, Company Information, and Scan Results

$164.97(as of Aug 1, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

iRhythm Technologies Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$164.97
Ticker SymbolIRTC
ExchangeNasdaq
SectorHealthcare
IndustryMedical Devices
Employees2,000
CountyUSA
Market Cap$5,300.1M
EBIDTA-47.4M
10-Day Moving Average138.91
P/E Ratio-57.09
20-Day Moving Average137.42
Forward P/E Ratio0.00
50-Day Moving Average142.55
Earnings per Share-3.13
200-Day Moving Average110.05
Profit Margin-7.62%
RSI76.41
Shares Outstanding32.1M
ATR5.78
52-Week High168.32
Volume1,883,850
52-Week Low55.92
Most Recent Support Level132.16
Book Value103.7M
Most Recent Resistance Level142.56
P/B Ratio50.91
Upper Keltner150.42
P/S Ratio8.03
Lower Keltner124.41
Debt-to-Equity Ratio150.42
Next Earnings Date10/30/2025
Cash Surplus176.9M
Next Ex-Dividend DateUnknown

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

iRhythm Technologies Inc In Our Stock Scanner

As of Aug 04, 2025
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Most Volatile StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.